Ionis Pharmaceuticals Inc
NASDAQ:IONS

Watchlist Manager
Ionis Pharmaceuticals Inc Logo
Ionis Pharmaceuticals Inc
NASDAQ:IONS
Watchlist
Price: 37.23 USD -1.46% Market Closed
Market Cap: 5.9B USD
Have any thoughts about
Ionis Pharmaceuticals Inc?
Write Note

Ionis Pharmaceuticals Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ionis Pharmaceuticals Inc
Total Receivables Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Ionis Pharmaceuticals Inc
NASDAQ:IONS
Total Receivables
$17.9m
CAGR 3-Years
25%
CAGR 5-Years
-18%
CAGR 10-Years
-4%
Abbvie Inc
NYSE:ABBV
Total Receivables
$11.5B
CAGR 3-Years
7%
CAGR 5-Years
16%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Total Receivables
$4.6B
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
5%
Amgen Inc
NASDAQ:AMGN
Total Receivables
$7.3B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Receivables
$1.8B
CAGR 3-Years
17%
CAGR 5-Years
32%
CAGR 10-Years
31%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Receivables
$6.1B
CAGR 3-Years
4%
CAGR 5-Years
18%
CAGR 10-Years
21%

See Also

What is Ionis Pharmaceuticals Inc's Total Receivables?
Total Receivables
17.9m USD

Based on the financial report for Sep 30, 2024, Ionis Pharmaceuticals Inc's Total Receivables amounts to 17.9m USD.

What is Ionis Pharmaceuticals Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
-4%

Over the last year, the Total Receivables growth was -87%. The average annual Total Receivables growth rates for Ionis Pharmaceuticals Inc have been 25% over the past three years , -18% over the past five years , and -4% over the past ten years .

Back to Top